Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Blackstein

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pathology, Research and Practice|October 7, 2004
Bone marrow metastasis of angiosarcomaChen Wang, Rola Rabah, Martin Blackstein, et al.
Cancer|January 29, 2008
Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic reviewShailendra Verma, Jawaid Younus, Denise Stys-Norman, et al.
Cancer Treatment Reviews|March 4, 2008
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcomaShailendra Verma, Jawaid Younus, Denise Stys-Norman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Histologic assessment of peritumoral edema in soft tissue sarcomaLawrence M White, Jay S Wunder, Robert S Bell, et al.
Cancer|June 22, 2010
Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapyAbha A Gupta, Alberto Pappo, Natasha Saunders, et al.
Journal of Surgical Oncology|December 6, 2017
Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challengesMai-Kim Gervais, Sally M Burtenshaw, Jessica Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcomaVivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Lancet (London, England)|November 27, 2012
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialGeorge D Demetri, Peter Reichardt, Yoon-Koo Kang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pathology, Research and Practice|October 7, 2004
Bone marrow metastasis of angiosarcomaChen Wang, Rola Rabah, Martin Blackstein, et al.
Cancer|January 29, 2008
Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic reviewShailendra Verma, Jawaid Younus, Denise Stys-Norman, et al.
Cancer Treatment Reviews|March 4, 2008
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcomaShailendra Verma, Jawaid Younus, Denise Stys-Norman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Histologic assessment of peritumoral edema in soft tissue sarcomaLawrence M White, Jay S Wunder, Robert S Bell, et al.
Cancer|June 22, 2010
Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapyAbha A Gupta, Alberto Pappo, Natasha Saunders, et al.
Journal of Surgical Oncology|December 6, 2017
Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challengesMai-Kim Gervais, Sally M Burtenshaw, Jessica Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcomaVivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Lancet (London, England)|November 27, 2012
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialGeorge D Demetri, Peter Reichardt, Yoon-Koo Kang, et al.
Pageof 1